Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial

Glaucoma leads to irreversible blindness. Numerous anti-glaucoma eye drops have been developed. Unfortunately, many patients with glaucoma still suffer from progressive visual disorders. Recently, ripasudil hydrochloride hydrate, a selective Rho-associated protein kinase inhibitor, was launched for...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Emi, Ishida, Waka, Sumi, Tamaki, Kishimoto, Tatsuma, Tada, Kentaro, Fukuda, Ken, Yoneda, Tsuyoshi, Kuroiwa, Hajime, Terao, Etsuko, Fujisawa, Yasuko, Nakakura, Shunsuke, Jian, Koji, Okumichi, Hideaki, Kiuchi, Yoshiaki, Fukushima, Atsuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403378/
https://www.ncbi.nlm.nih.gov/pubmed/30842572
http://dx.doi.org/10.1038/s41598-019-40255-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403378/
https://www.ncbi.nlm.nih.gov/pubmed/30842572
http://dx.doi.org/10.1038/s41598-019-40255-9

Ejemplares similares